We could not find any results for your search.
Try a different term, or tell us what you need and we will point you in the right direction:
Metabolic Center
The unit
The High-Risk Gastrointestinal Oncology Unit at the Publio Cordón Memorial Hospital offers specialist medical care for the assessment, prevention and monitoring of the risk of cancer of the digestive system. Its approach is based on a rigorous clinical assessment and patient-centred care, taking the time to explain and supporting patients in their decision-making.
Medical team
High-quality endoscopy in cancer prevention and the early detection of lesions
Resection of early-stage tumours of the digestive tract
Advanced therapeutic endoscopy, oncological endoscopy and minimally invasive endoscopic surgery
Patient information
The High-Risk Gastrointestinal Oncology Unit, which forms part of the Gastroenterology department and is headed by Dr Marta Cruz Aparicio, specialises in the assessment, prevention and monitoring of the risk of cancer of the gastrointestinal tract. Its work focuses on the early identification of clinical situations requiring treatment or specific monitoring, adopting a cautious and proportionate approach.
The unit’s work is based on a rigorous analysis of individual risk and the correct indication for each test and treatment, avoiding both the underestimation of risk and the performance of unnecessary investigations.
The unit cares for people who do not have cancer at the time of assessment and who wish to take proactive measures against potential digestive health problems, both in the absence of any known history and where there is an increased risk due to family history, genetic factors, polyps or other predisposing clinical conditions.
It also provides follow-up care for people who have survived cancer and are at risk of developing a second digestive tract tumour.
The aim is to detect the disease at an early stage through strategies for early detection, prevention and monitoring tailored to each clinical situation, with follow-up tailored to the individual’s profile, age and changing risk profile.
The unit’s work focuses on the assessment and monitoring of:
People with no known family history who wish to undergo a specialist preventive assessment.
A family history of gastrointestinal cancer (colon, stomach, pancreas or oesophagus).
Hereditary tumour predisposition syndromes, such as Lynch syndrome.
Gastrointestinal polyps with the potential to progress, particularly when they are multiple or advanced.
Conditions associated with an increased risk of gastrointestinal cancer, such as Barrett’s oesophagus, chronic atrophic gastritis or long-standing inflammatory bowel disease.
Cancer survivors at risk of second digestive tract tumours.
In all these cases, a specialist assessment enables individual risk to be stratified, an appropriate follow-up plan to be established, and potential complications to be anticipated through personalised preventive strategies.
Each patient is assessed on an individual basis, taking into account their personal and family medical history and selecting the most appropriate investigations based on their risk profile.
Decisions are based on expert judgement and the correct indication for each test, prioritising those investigations that provide relevant clinical information and avoiding unnecessary procedures. This process is carried out in coordination with other gastroenterology units and with various hospital departments when the clinical situation requires it.
Prevention and monitoring are organised through personalised plans tailored to each person’s age, clinical context and changing risk profile.
Follow-up is conceived as an organised and reviewable process, which enables potential changes to be anticipated and facilitates informed decisions over time.
In situations where lesions are identified at a very early stage, such as certain early-stage gastrointestinal tumours — particularly early-stage gastric cancer — the unit has the expertise and resources to assess and carry out advanced endoscopic treatments, such as endoscopic tumour resection, as part of a conservative and carefully indicated approach.
The unit comprises specialists with specific expertise in the prevention and clinical monitoring of gastrointestinal cancer risk, a field that requires continuity of care and the appropriate selection of tests over time.
Where necessary, care is coordinated between the Gastroenterology, Clinical Genetics, Medical Oncology and General and Gastrointestinal Surgery departments, integrating each patient’s clinical and progress data into a single follow-up plan.
This care model prioritises understanding the actual risk, providing support throughout the process, allowing sufficient time to explain each finding, and facilitating informed decision-making, within a predictable, rigorous and safe clinical environment.
Specialist care for comprehensive risk assessment and the planning of clinical follow-up.
Related content
At Memorial Publio Cordón Hospital we understand that taking the first step is also part of your care. Our team will handle your request and guide you to the most suitable professional, specialty or service.
Write to us or give us a call and we will get back to you with personalised assistance.
Patient care
Would you rather we called you?
Leave us your details and the reason for your enquiry. We will get back to you with the guidance you need.
Request guidance 24-hour emergency care Call now · 913 548 990 International patientsChoose whichever of these three options is easiest for you.
Leave us your details and we will call you back as soon as possible.
The form below is in Spanish. If you would rather be assisted in English, please call us or request a call back.
Fill in the form below to arrange your medical appointment.
The form below is in Spanish. If you would rather be assisted in English, please call us or request a call back.
